期刊文献+

稳心颗粒联合可达龙治疗对急性冠脉综合征校正的QT间期离散度及快速型心律失常的影响 被引量:2

Effect of Wenxinkeli Combined with Cordarone on QT Corrected Dispersion and Ventricular Arrhythmia in Patients with Acute Coronary Syndrome
下载PDF
导出
摘要 目的:观察稳心颗粒联合可达龙对急性冠脉综合征(ACS)患者校正QT离散度(QTcd)及室性快速型心律失常的影响。方法:163例ACS病人随机分为两组,两组均按指南给予可达龙+标准化治疗,治疗组在此基础上加用稳心颗粒,疗程10d,观察两组ACS病人治疗前后QTcd的变化以及室性快速型心律失常的发生率。结果:两组ACS病人治疗后QTcd均有减少,而稳心颗粒组更为明显,差异有显著性(P<0.05),稳心颗粒组快速型心律失常的发生率减少更为明显(P<0.05)。结论:稳心颗粒联合可达龙可以明显降低ACS病人的QTcd,减少快速型心律失常的发生率。 Objective: To observe the effect of Wenxinkeli combined with cordarone on QT corrected dispersion(QTcd) and ventricular arrhythmia in patients with acute coronary syndrome(ACS).Method:163 patients with ACS were randomly divided into two groups:group A with routine treatment and Cordarone,group B added Wenxinkeli.The two groups were treated for 10 days.The QTcd of two groups were measured before and after treatment.The arrhythmia was recorded by 24 hour electrocardiogram monitors.The group before treatment was compared with that after treatment.Result:The QTcd of two groups was decreased after treatment,especially in group B.There's significant between the patients before and after Wenxinkeli treatment for 4 weeks(P〈0.05).Incidence of arrhythmia was obviously reduced in group B(P〈0.05).Conclusion: Wenxinkeli combined with cordarone treatment effectively,which can reduce the QTcd which can cut down the incidence of arrhythmia in ACS patients.
出处 《河北医学》 CAS 2010年第8期926-928,共3页 Hebei Medicine
关键词 稳心颗粒 急性冠状动脉综合征 QT间期离散度 快速型心律失常 Wenxinkeli Acute coronary syndrome QT corrected dispersion Arrhythmia
  • 相关文献

参考文献5

二级参考文献14

  • 1张治德,高旭.胺碘酮治疗急性心肌梗死伴心律失常120例临床观察[J].实用全科医学,2006,4(5):568-568. 被引量:11
  • 2[1]Botto GL, Bonini W, Broffoni T, et al. Regular ventricular rhythms before conversion of recent onset atrial fibrillation to sinus rhythm [ J ]. PACE,1994,17:2114
  • 3[2]Weiner P, Ganam R, Xidan F, et al. Clinical course of recent onset atrial fibrillation treated with oral propafenone [J]. Chest , 1994,105:1013
  • 4[3]Lewis RV. Atrial fibrillation .The therapeutic options [ J]. Drugs , 1990,40(6) :841
  • 5[4]Doval HC, Nul DR, Grancelli HD, et al. for GESICA. Randomised trial of low-dose amiodarone in severe congestive heart failure [ J ]. Lancet ,1994,344:493
  • 6[5]Singh SN, Fletcher RD, Fisher SG, et al. Amiodarone in patients with con gestive heart failure and asymptomatic ventricular arrhythmia [J]. N Engl J Med, 1995,333:77
  • 7[6]Kerin NZ, Faitel K, Naini M. The efficacy of intraverous amiodarone for the conversion of chronic atrial fibrillation [J]. Arch Intern Med, 1996, 156:49
  • 8[7]Galve E, Rius T, Ballester R, et al. Intraverous amiodarone in treatment of recent-onset atrial fibrillation:result of randomized, controlled study [ J]. J Am Coll Cardiol, 1996,27:1079
  • 9[8]Clomo HF, Wood MA, Gilliqan DM. Intraverous amiodarone for acute heart rate control in the critically iii patient with atrial tachyarrhythmias [J] .J Am Cardiol, 1998 , 81: 594
  • 10张洁.QT离散度[J].国外医学(心血管疾病分册),1997,24(1):3-6. 被引量:68

共引文献310

同被引文献12

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部